Market Overview

UPDATE: Bank of America Reiterates on National Health Investors Following Mixed 4Q Results

Related NHI
Earnings Scheduled For May 6, 2016
Benzinga's Top Upgrades
My Portfolio Update And Review Of 83 Stocks: Up 2 With Reynolds And Exelon, Down 1 With Apple (Seeking Alpha)

In a report published Thursday, Bank of America analyst Juan C. Sanabria reiterated an Underweight rating on National Health Investors (NYSE: NHI), but lowered the price target from $65.00 to $63.50.

In the report, Bank of America noted, “Within our coverage, healthcare REIT earnings results were mixed. HCN, HCP & NHI exceeded; AVIV, SNH & VTR met; and MPW missed. AVIV, HCN, HCP, MPW & NHI all initiated 2014 guidance below Street expectations due largely to the exclusion of future acquisitions in company forecasts. VTR was the only REIT that initiated guidance in line with expectations. SNH does not provide guidance. Specifically, VTR initiated same store (SS) cash NOI growth guidance of 3-4% across its portfolio, and is expecting SS RIDEA growth of 4-6%. HCN is expecting 3-3.5% overall SS cash NOI growth with RIDEA 5% or greater. HCP is forecasting 3-4% overall cash SS NOI growth with senior housing at 3.5-4.5%.”

National Health Investors closed on Wednesday at $63.11.

Latest Ratings for NHI

Mar 2016Bank of AmericaUpgradesUnderperformNeutral
Nov 2015Stifel NicolausMaintainsBuy
Sep 2015Mizuho SecuritiesMaintainsNeutral

View More Analyst Ratings for NHI
View the Latest Analyst Ratings

Posted-In: Bank of America Juan C. SanabriaAnalyst Color Price Target Analyst Ratings


Related Articles (NHI)

View Comments and Join the Discussion!